Cervical Cancer Survivor Advocates for HPV Vaccination as Key Project Ends

Nathalie Stoltz, a young cervical cancer survivor, is passionately advocating for HPV vaccinations as Sweden approaches the conclusion of its cervical cancer eradication project on June 30, 2025. Stoltz, who experienced significant health challenges due to HPV-related cervical cancer, emphasizes the critical role of vaccination in preventing the disease that is primarily caused by the human papillomavirus (HPV). Currently, cervical cancer is notably the third most prevalent cancer among women aged 20 to 49 in Sweden, presenting an 80% survival rate within five years post-diagnosis but often leading to severe treatment side effects such as infertility and long-term disabilities.

Since 2012, the Swedish government has implemented an eradication initiative offering free HPV vaccinations to girls, aiming for a vaccination rate of 70% within the target demographic by the project's end. However, it has fallen short, achieving only a 63% national vaccination rate, with just six of Sweden's regions meeting the goal. Professor Joakim Dillner, project leader, remains hopeful that a significant reduction in HPV prevalence can still be achieved despite these shortcomings. Stoltz has raised concerns that the premature conclusion of the project may be motivated by financial factors rather than health priorities. After the project's expiration, many regions plan to continue providing free HPV vaccinations to individuals up to 27 years old, although some will start charging fees. Stoltz urges, “Vaccination is vital for saving lives and fighting this preventable disease.”